CPMKG

CPMKG compiles condition-based knowledge entries for precision medicine, enabling drug-centric exploration and condition-based multiknowledge inference across drug side effects, drug sensitivity, drug mechanisms, and drug indications.

Key Features:

• Conditional Knowledge Representation: Uses conditional events as the basic data structure to capture complex multirelationships and conditions affecting specific individuals with particular genetic backgrounds.
• Large-Scale Knowledge Compilation: Contains 307,614 knowledge entries encompassing thousands of drugs, diseases, phenotypes (complications/side effects), genes, and genomic variations.
• Drug-Centric Exploration: Enables exploration of drug-related knowledge across four categories: drug side effects, drug sensitivity, drug mechanisms, and drug indications.
• Condition-Based Multiknowledge Inference: Supports inference across multiple knowledge types conditioned on patient-specific factors including genetic profiles, syndromes, and phenotypes.
• Large Language Model Integration: Integrates a large language model to provide textual interpretations of subgraph data, bridging structured graph data with natural language expressions.

Scientific Applications:

• Personalized Disease Treatment: Provides drug information tailored to personalized genetic profiles, syndromes, and phenotypes for clinical research and treatment optimization.
• Drug Side Effect Prediction: Supports identification of complications and side effects specific to patient genetic backgrounds.
• Drug Sensitivity Analysis: Enables assessment of drug effectiveness and dosage optimization based on individual genetic characteristics.
• Drug Mechanism Elucidation: Facilitates understanding of molecular mechanisms underlying drug responses in stratified patient populations.
• Drug Indication Discovery: Accelerates identification of appropriate drug indications through condition-based knowledge inference.

Methodology:

CPMKG was constructed through information extraction and meticulous curation of genetic-specific knowledge from stratified research and clinical trials.